Although prior research has linked mutations or dysregulation of MYCBP2 with various disorders, such as neurodegenerative diseases and cancers, its specific functions in the CNS, especially in the modulation of microglial polarization following SCI, have not been fully elucidated. This evidence concerns the gene MYCBP2 and neurodegenerative disease.